PREMELVAX LIMITED
30 CITY ROAD, LONDON EC1Y 2AB- Active
- Private Limited Company
- Company No. 14647799
- Last Updated: 01 Mar 2024
Company Profile
PREMELVAX LIMITED was incorporated on Wednesday, February 8, 2023 as a Private Limited Company with registered address in LONDON. PREMELVAX LIMITED has the status: Active and it's listed in the following category: Research and experimental development on biotechnology. This Private Limited Company has been operating for 1 year 9 months and 1 day.
| Name | PREMELVAX LIMITED |
|---|---|
| Company number | 14647799 |
| Company type | Private Limited Company |
| Incorporation date | 08 Feb 2023 |
| Status | Active |
| Industry (SIC 2007) |
Address
| Registered Address |
30 CITY ROAD LONDON EC1Y 2AB |
|---|---|
| Country Of Origin | UNITED KINGDOM |
Map based on PostCode
Ownership Information
Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.
| Name | Nature of Control |
|---|---|
| Professor Andrzej Mackiewicz Nationality: Polish |
Dates: Wednesday, February 8, 2023 - present
ownership of shares 50 to 75 percent
voting rights 50 to 75 percent
|
| Mr Michael Peter Hugh Fox Nationality: British |
Dates: Wednesday, February 8, 2023 - Wednesday, February 8, 2023
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
| International Claim Strategies Limited Manchester Street, W1U 4DJ |
Dates: Wednesday, February 8, 2023 - present
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent
|
Accounts and Confirmation
| Type of accounts | NO ACCOUNTS FILED |
|---|---|
| End of financial Year | 28 February |
| Next annual accounts due | 08 November 2024, (-1 days left) |
| Latest accounts | Not available |
| Next confirmation statement due | 07 March 2024 |
| Last confirmation statement dated | Not available |
Mortgages
No mortgages have been registered against PREMELVAX LIMITED.
Previous Names
| Name | Change Date |
|---|---|
| PREMELVAX LIMITED | 08 Feb 2023 |